Product Information
QUETIAPINE ER 150 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.2058 per EA under NDC 50742063660. Its NADAC has been published 380 times since Dec 27, 2017.
FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the quetiapine fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742063660
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
3/19/2025
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA208947FDA Approved
11/29/2017
TE Code
AB
On Market Since
8/31/2017
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 150 MG TABLET has been published 380 times since Dec 27, 2017, and over the history we have for it it has declined 77.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2058 per EA |
|---|---|
| All-time high | $0.9786 (Feb 14, 2018) |
| All-time low | $0.1497 (Nov 20, 2024) |
| Median price | $0.3201 |
| Average price | $0.3527 |
| Largest weekly change | +43.5% (Apr 21, 2021) |
| Weeks tracked | 380 |
| Tracking since | Dec 27, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-1.1%
5Y
-35.7%
All
-77.2%
Last surveyed Apr 2, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the quetiapine fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 150 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.2058 per EA (NDC 50742063660), effective Apr 2, 2025.
How has the price of QUETIAPINE ER 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 150 MG TABLET has declined 77.2%. It has been tracked across 380 weekly CMS publications since Dec 27, 2017.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 150 MG TABLET?
Since Dec 27, 2017, the NADAC for QUETIAPINE ER 150 MG TABLET has ranged from a low of $0.1497 (Nov 20, 2024) to a high of $0.9786 (Feb 14, 2018), with a median of $0.3201 per EA.
Are there cheaper alternatives to QUETIAPINE ER 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of QUETIAPINE ER 150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUETIAPINE ER 150 MG TABLET?
QUETIAPINE ER 150 MG TABLET (NDC 50742063660) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.